Javier Q. F.
- Country
- Spain
- Department
- Cardiologia
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Obicetrapib vs Bempedoic Acid on Maximally Tolerated Lipid‑Lowering Therapy in High‑Risk Dyslipidemia: A Randomized Double‑Blind Study
- Phase 2b/3 Randomized Double‑Blind Placebo‑Controlled Trial of Ataciguat to Slow Progression and Improve Peak VO2 in Moderate Calcific Aortic Valve Stenosis
Data & Insights
Has run more than one trial at 132 of 647 partner sites.
Specializations
Cardiovascular disease and lipid management
Clinical research includes atherosclerotic cardiovascular disease, established cardiovascular disease, high cardiovascular risk, and hypertension, with interest in therapies targeting elevated lipoprotein(a) and broader dyslipidemia.
- MACE-4 risk reduction
- Lipoprotein(a) lowering
- Blood pressure control
- LDL-C reduction
Work in this area also reflects involvement in prevention-focused cardiovascular innovation for patients with residual cardiometabolic risk.
Respiratory medicine and allergic inflammation
The investigator is active in studies of asthma and chronic spontaneous urticaria, with additional interest in inflammatory airway and skin-itch disorders such as prurigo nodularis.
- Uncontrolled asthma
- Asthma exacerbations
- Urticaria activity
- Pruritus
This therapeutic focus spans biologic approaches for type 2 inflammation and symptom control in chronic allergic disease.
Dermatology and immune-mediated skin disease
Research activity includes acne vulgaris and prurigo nodularis, alongside inflammatory conditions linked to itch and skin barrier dysfunction.
- Acne vulgaris
- Prurigo nodularis
- Chronic itch
- Topical therapy
These studies connect dermatologic care with novel anti-inflammatory and symptom-directed treatment strategies.
Gastroenterology and autoimmune disease
Clinical involvement extends to coeliac disease and primary Sjögren’s disease, with additional work in rheumatoid arthritis and other rheumatologic disease settings.
- Non-responsive coeliac disease
- Primary Sjögren’s disease
- Rheumatoid arthritis
- Systemic immune activity
The therapeutic scope includes immune modulation across gastrointestinal and systemic autoimmune disorders.
Neurology, metabolic disease, and preventive immunisation
Research interests also cover episodic migraine, chronic migraine, menstrual migraine, obesity, Rett syndrome, and influenza immunisation.
- Migraine prevention
- Weight management
- Neurodevelopmental disorders
- Influenza vaccine response
This portfolio includes neurologic symptom prevention, metabolic intervention, and vaccine-related clinical research.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.